Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
08/12/19 8-K Current report filing
Related Documents
8
08/12/19 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
63
08/02/19 8-K Current report filing
Related Documents
5
07/25/19 8-K Current report filing
Related Documents
5
07/16/19 POS EX Post-effective amendment filed solely to add exhibits to a registration statement
Related Documents
6
07/16/19 424B4 Prospectus filed pursuant to Rule 424(b)(4) 36
07/16/19 8-K Current report filing
Related Documents
5
07/15/19 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
07/15/19 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
07/15/19 EFFECT Notice of Effectiveness 1